Lilly Bars Contract Pharmacies From 340B Discounts Despite HRSA Guidance
Executive Summary
Distribution limits for Cialis prompts concerns among 340B-eligible providers that Lilly will impose similar restrictions for additional products and that other manufacturers may follow suit.
You may also be interested in...
Pharma Manufacturers Mobilize Against 340B Discounts At Contract Pharmacies
AstraZeneca, Merck & Co., Sanofi and Novartis join Eli Lilly in taking action. But providers in the US federal discount program are pushing back.
340B Reform: US House Bills Mark The End Of The Beginning
Energy & Commerce Health Subcommittee releases several discussion drafts at hearing on 340B drug discount program reform as the debate seems poised to move into the next phase.
Many 340B Providers May Not Pass On Discounts Through Contract Pharmacies – GAO
House Energy and Commerce Committee releases US Government Accountability Office analysis of 340B contract pharmacies.